Patent portfolios: maximise the value and minimise the cost

According to patent information company IFI Claims, 66% of what it said were the most prolific patenting companies also feature in the Financial Times’stop 500—compelling evidence that research and development (R&D) today creates tomorrow’s successes.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

Foley & Lardner adds litigation and transaction expert in New York

UPC deals further blow to Dexcom in glucose monitor dispute with Abbott

‘A marathon and a sprint at the same time’: How we won $452m damages

LSPN Europe: Navigating the EPO and lessons from the UPC frontline

Paul Hastings reinforces London office with high-tech patent litigator

Comparing life sciences IP in Brazil and the US

Patent portfolios: maximise the value and minimise the cost

Editor's picks

Editor's picks

More features